BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,291 | -32.5% | 7,829 | -8.4% | 0.02% | -31.8% |
| Q2 2023 | $369,408 | +5.1% | 8,543 | -1.4% | 0.02% | 0.0% |
| Q1 2023 | $351,511 | -29.5% | 8,666 | -11.4% | 0.02% | -35.3% |
| Q4 2022 | $498,394 | -5.4% | 9,778 | -0.1% | 0.03% | -15.0% |
| Q3 2022 | $527,000 | -14.0% | 9,783 | +2.5% | 0.04% | -13.0% |
| Q2 2022 | $613,000 | -19.6% | 9,546 | -2.9% | 0.05% | -8.0% |
| Q1 2022 | $762,000 | -11.4% | 9,828 | -1.9% | 0.05% | -18.0% |
| Q4 2021 | $860,000 | -2.9% | 10,022 | -9.0% | 0.06% | -12.9% |
| Q3 2021 | $886,000 | -0.9% | 11,016 | -0.8% | 0.07% | -2.8% |
| Q2 2021 | $894,000 | -13.5% | 11,109 | -9.3% | 0.07% | -20.0% |
| Q1 2021 | $1,033,000 | +5.2% | 12,248 | +0.1% | 0.09% | -3.2% |
| Q4 2020 | $982,000 | -1.4% | 12,239 | -1.2% | 0.09% | -17.7% |
| Q3 2020 | $996,000 | -5.9% | 12,387 | +0.7% | 0.11% | -14.4% |
| Q2 2020 | $1,059,000 | +2.2% | 12,303 | -3.6% | 0.13% | -15.4% |
| Q1 2020 | $1,036,000 | -5.6% | 12,766 | -2.8% | 0.16% | +32.2% |
| Q4 2019 | $1,098,000 | -5.8% | 13,129 | -1.5% | 0.12% | -18.6% |
| Q3 2019 | $1,166,000 | +6.9% | 13,333 | +0.0% | 0.14% | +9.0% |
| Q2 2019 | $1,091,000 | +2.7% | 13,327 | +2.1% | 0.13% | -2.9% |
| Q1 2019 | $1,062,000 | +23.6% | 13,058 | +0.0% | 0.14% | +6.2% |
| Q4 2018 | $859,000 | -12.6% | 13,052 | +2.4% | 0.13% | -1.5% |
| Q3 2018 | $983,000 | +2.4% | 12,747 | -2.0% | 0.13% | -3.0% |
| Q2 2018 | $960,000 | +13.6% | 13,003 | +0.0% | 0.14% | +12.5% |
| Q1 2018 | $845,000 | +0.6% | 12,998 | +0.0% | 0.12% | +0.8% |
| Q4 2017 | $840,000 | +3.1% | 12,994 | +0.0% | 0.12% | -4.0% |
| Q3 2017 | $815,000 | +3.7% | 12,989 | +0.0% | 0.12% | -0.8% |
| Q2 2017 | $786,000 | +16.8% | 12,984 | +0.0% | 0.12% | +8.7% |
| Q1 2017 | $673,000 | +18.9% | 12,979 | +1.7% | 0.12% | +8.5% |
| Q4 2016 | $566,000 | -8.1% | 12,764 | -1.4% | 0.11% | -15.9% |
| Q3 2016 | $616,000 | +6.6% | 12,949 | +1.4% | 0.13% | +0.8% |
| Q2 2016 | $578,000 | +10.1% | 12,774 | +0.0% | 0.12% | +5.0% |
| Q1 2016 | $525,000 | +3.8% | 12,769 | -3.8% | 0.12% | -2.5% |
| Q4 2015 | $506,000 | -4.3% | 13,268 | -17.7% | 0.12% | -10.9% |
| Q3 2015 | $529,000 | -8.3% | 16,112 | +5.1% | 0.14% | -3.5% |
| Q2 2015 | $577,000 | -43.7% | 15,327 | +2.4% | 0.14% | -47.0% |
| Q1 2015 | $1,025,000 | -6.6% | 14,967 | +0.0% | 0.27% | -11.3% |
| Q4 2014 | $1,097,000 | -0.2% | 14,962 | -2.3% | 0.30% | -6.8% |
| Q3 2014 | $1,099,000 | -2.3% | 15,317 | -1.6% | 0.32% | -2.4% |
| Q2 2014 | $1,125,000 | -2.3% | 15,566 | -0.5% | 0.33% | -9.5% |
| Q1 2014 | $1,151,000 | +5.7% | 15,638 | -0.1% | 0.37% | +2.2% |
| Q4 2013 | $1,089,000 | +5.4% | 15,661 | -0.4% | 0.36% | -4.3% |
| Q3 2013 | $1,033,000 | -10.4% | 15,725 | -5.5% | 0.38% | -18.5% |
| Q2 2013 | $1,153,000 | – | 16,648 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |